A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

NCT02222493 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

NCT00760669 ·Status: COMPLETED

A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis

NCT00051623 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)

NCT00794898 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis

NCT00691028 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

NCT00299130 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

NCT00299104 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

NCT00298272 ·Status: TERMINATED ·Phase: PHASE2

A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)

NCT00202852 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis

NCT00487825 ·Status: COMPLETED ·Phase: PHASE2

Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

NCT00317538 ·Status: COMPLETED ·Phase: PHASE3

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

NCT02728934 ·Status: COMPLETED

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

NCT01999192 ·Status: TERMINATED ·Phase: PHASE2

An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT00264550 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)

NCT00727298 ·Status: COMPLETED

A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy

NCT00689728 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

NCT00299546 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

NCT00264537 ·Status: COMPLETED ·Phase: PHASE3

Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)

NCT01308255 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

NCT00243412 ·Status: COMPLETED ·Phase: PHASE2

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT00361335 ·Status: COMPLETED ·Phase: PHASE3

Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)

NCT00367237 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

NCT00207714 ·Status: COMPLETED ·Phase: PHASE2

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

NCT01526057 ·Status: COMPLETED ·Phase: PHASE2

Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

NCT01004432 ·Status: COMPLETED ·Phase: PHASE3